Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
-
Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
-
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
PAVmed's (PAVM) Lucid Diagnostics Files For a Proposed IPO
-
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
-
PAVmed to Participate in September Investor and MedTech Conferences
-
PAVmed Provides Business Update and First Quarter 2021 Financial Results
-
PAVmed Announces Closing of its Public Offering of Common Stock
-
PAVmed (PAVM) Prices 9.8M Share Common Offering for Gross Proceeds of Approx. $45M
-
PAVmed Announces Pricing of $45 Million Public Offering of Common Stock
-
PAVmed (PAVM) to Offer Common Stock
-
PAVmed Announces Proposed Public Offering of Common Stock
-
PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020
